Entheon Biomedical Corp. reported earnings results for the full year ended November 30, 2021. For the full year, the company reported sales was CAD 0.02167 million.
Net loss was CAD 8.89 million compared to CAD 4.38 million a year ago. Basic loss per share from continuing operations was CAD 0.16 compared to CAD 0.16 a year ago.